Literature DB >> 3018962

High frequency of HLA-DR5 in Greek patients with haemophilia A and haemophilia B.

C Papasteriades, M Varla, J Economidou, K Marcacis, C Mitsouli, K Louisou, T Mandalaki, A Roumeliotou, G Papaevangelou.   

Abstract

Sixty unrelated Greek patients with haemophilia (46 with haemophilia A and 14 with haemophilia B) were typed for HLA-A, B and DR antigens. A highly significant increase in the frequency of HLA-DR5 was observed in both groups of patients (58.6% vs 30.0%, chi 2 = 10.47, pc less than 0.03, RR = 3.31 for haemophilia A and 78.5% vs 30.0%, chi 2 = 12.32, pc less than 0.007, RR = 8.5 for haemophilia B). An increased frequency of HLA-B13 was also observed in patients with haemophilia A (15.2% vs 5.7%, chi 2 = 5.74, pc less than 0.4, RR = 2.9). Thirty of the 60 patients (50.0%) were positive for LAV/HTLVIII antibodies. HLA-DR5 was equally distributed in patients with and without these antibodies (63.3% and 63.3%, respectively). The presence of DR5 did not correlate with the severity of haemophilia A or B. These results may suggest an influence of gene(s) on chromosome 6 in haemophilia A and haemophilia B and no effect of HLA antigens in the susceptibility to LAV/ HTLVIII infection among haemophiliac patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018962     DOI: 10.1111/j.1399-0039.1986.tb00465.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  2 in total

1.  Anti HTLV-I antibodies and HLA phenotypes in the West Indies.

Authors:  M Chavance; N Monplaisir; I Valette; L Schaffar-Deshayes; C Raffoux
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

2.  Evidence of HIV exposure and transient seroreactivity in archived HIV-negative severe hemophiliac sera.

Authors:  Scott A Tenenbaum; Cindy A Morris; Steve S Alexander; Harris E McFerrin; Robert F Garry; Cindy A Leissinger
Journal:  Virol J       Date:  2005-08-17       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.